ArticleBMC complementary medicine and therapies2025

Astragaloside IV attenuates glucocorticoid-induced osteoclastogenesis and bone loss via the MAPK/NF-κB pathway.

Chun Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.